☰

Andrew J. Skildum, Ph.D. - Publications

Affiliations: 
2002 Michigan State University, East Lansing, MI 
Area:
Cell Biology, Oncology
Tree Info Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Dornfeld K, Bjork J, Folkert G, Skildum A, Wallace KB. Mitochondrial activities play a pivotal role in regulating cell cycle in response to doxorubicin. Cell Cycle (Georgetown, Tex.). 1-13. PMID 33978554 DOI: 10.1080/15384101.2021.1919839  0.397
2017 Zhou K, Diebel KW, Holy J, Skildum A, Odean E, Hicks DA, Schotl B, Abrahante JE, Spillman MA, Bemis LT. A tRNA fragment, tRF5-Glu, regulates BCAR3 expression and proliferation in ovarian cancer cells. Oncotarget. 8: 95377-95391. PMID 29221134 DOI: 10.18632/Oncotarget.20709  0.546
2015 Walter W, Thomalla J, Bruhn J, Fagan DH, Zehowski C, Yee D, Skildum A. Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cells. Springerplus. 4: 689. PMID 26576332 DOI: 10.1186/S40064-015-1444-2  0.604
2015 Dornfeld K, Madden M, Skildum A, Wallace KB. Aspartate facilitates mitochondrial function, growth arrest and survival during doxorubicin exposure. Cell Cycle (Georgetown, Tex.). 14: 3282-91. PMID 26317891 DOI: 10.1080/15384101.2015.1087619  0.328
2015 Deus CM, Zehowski C, Nordgren K, Wallace KB, Skildum A, Oliveira PJ. Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts. Toxicology. 334: 1-11. PMID 25997894 DOI: 10.1016/J.Tox.2015.05.001  0.472
2015 Nordgren KK, Skildum AJ. The deep end of the metabolite pool: influences on epigenetic regulatory mechanisms in cancer. European Journal of Clinical Investigation. 45: 9-15. PMID 25524581 DOI: 10.1111/Eci.12361  0.329
2012 Barbosa IA, Machado NG, Skildum AJ, Scott PM, Oliveira PJ. Mitochondrial remodeling in cancer metabolism and survival: potential for new therapies. Biochimica Et Biophysica Acta. 1826: 238-54. PMID 22554970 DOI: 10.1016/J.Bbcan.2012.04.005  0.424
2011 Skildum A, Dornfeld K, Wallace K. Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance. Breast Cancer Research and Treatment. 129: 785-97. PMID 21128112 DOI: 10.1007/S10549-010-1268-2  0.594
2010 Greene A, Parke D, Gingery A, Zhdankin O, Skildum A, Holy J, Perkins E, Rose‐Hellekant TA. Abstract B88: Local delivery of breast cancer chemopreventives using mesenchymal stem cells Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B88  0.543
2009 Rose-Hellekant TA, Skildum AJ, Zhdankin O, Greene AL, Regal RR, Kundel KD, Kundel DW. Short-term prophylactic tamoxifen reduces the incidence of antiestrogen-resistant/estrogen receptor-positive/progesterone receptor-negative mammary tumors. Cancer Prevention Research (Philadelphia, Pa.). 2: 496-502. PMID 19401525 DOI: 10.1158/1940-6207.Capr-09-0002  0.41
2009 Greene A, Parke D, Zhdankin O, Gingery A, Skildum A, Holy J, Perkins E, Rose‐Hellekant T. Abstract A197: Development of an immunocompetent, triple negative, breast cancer model for stem cell based delivery of therapeutics Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A197  0.587
2008 Zhang H, Skildum A, Stromquist E, Rose-Hellekant T, Chang LC. Bioactive Polybrominated Diphenyl Ethers from the Marine Sponge Dysidea sp Journal of Natural Products. 71: 262-264. PMID 18198840 DOI: 10.1021/Np070244Y  0.449
2007 Varma H, Skildum AJ, Conrad SE. Functional ablation of pRb activates Cdk2 and causes antiestrogen resistance in human breast cancer cells. Plos One. 2: e1256. PMID 18060053 DOI: 10.1371/Journal.Pone.0001256  0.618
2007 Daniel AR, Qiu M, Faivre EJ, Ostrander JH, Skildum A, Lange CA. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids. 72: 188-201. PMID 17173941 DOI: 10.1016/J.Steroids.2006.11.009  0.569
2005 Faivre E, Skildum A, Pierson-Mullany L, Lange CA. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators. Steroids. 70: 418-26. PMID 15862825 DOI: 10.1016/J.Steroids.2005.02.012  0.626
2005 Skildum A, Faivre E, Lange CA. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Molecular Endocrinology (Baltimore, Md.). 19: 327-39. PMID 15486045 DOI: 10.1210/Me.2004-0306  0.635
2003 Pierson-Mullany LK, Skildum A, Faivre E, Lange CA. Cross-talk between growth factor and progesterone receptor signaling pathways: implications for breast cancer cell growth. Breast Disease. 18: 21-31. PMID 15687686 DOI: 10.3233/Bd-2003-18104  0.566
2002 Skildum AJ, Mukherjee S, Conrad SE. The cyclin-dependent kinase inhibitor p21WAF1/Cip1 is an antiestrogen-regulated inhibitor of Cdk4 in human breast cancer cells. The Journal of Biological Chemistry. 277: 5145-52. PMID 11741909 DOI: 10.1074/Jbc.M109179200  0.628
Show low-probability matches.